Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure

Journal of the American College of Cardiology

Volumn 37, Issue 5, 2001, Pages 1246-1251

  Aggarwal, Anuradha ^a   Esler, Murray D ^a   Socratous, Flora ^a   Kaye, David M ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; CATECHOLAMINE; CLONIDINE; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BRACHIAL ARTERY; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOSE RESPONSE; FEEDBACK SYSTEM; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MALE; NORADRENALIN RELEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; STATISTICAL ANALYSIS; SYMPATHETIC TONE;

AGED; CLONIDINE; DOWN-REGULATION; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, PRESYNAPTIC;

EID: 0035312887     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01121-4     Document Type: Article

References (27)

1. Neurohormonal interactions and adaptations in congestive heart failure
2. Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity
3. Overflow of catecholamine neurotransmitters to the circulation: Source, fate, and functions
4. Adverse consequences of high sympathetic nervous activity in the failing human heart
5. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
6. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias
7. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: U.S. Carvedilol Heart Failure Study Group
8. Elevation of plasma neuropeptide Y levels in congestive heart failure
9. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure
10. Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure
11. Alpha-adrenergic component of the sympathetic nervous system in congestive heart failure
12. Prejunctional alpha 2-adrenoceptors and norepinephrine release in the forearm of normal humans
13. Functional significance of presynaptic alpha-adrenergic receptors in failing and nonfailing human left ventricle
14. Cardiac and systemic sympathetic activity in response to clonidine in human heart failure
15. The central hypotensive effect of clonidine: Studies in tetraplegic subjects
16. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension
17. Determination of norepinephrine apparent release rate and clearance in humans
18. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man
19. Tracer norepinephrine kinetics: Dependence on regional blood flow and the site of infusion
20. Suppressing sympathetic activation in congestive heart failure: A new therapeutic strategy
21. Evidence for functional alpha 2-adrenoceptors on vascular sympathetic nerve endings in the human forearm
22. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts
23. Platelet alpha 2 adrenoreceptors in chronic congestive heart failure
24. Sympathoinhibitory response to clonidine is blunted in patients with heart failure
25. Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites?
26. The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure: Moxonidine Investigators
27. The role of presynaptic feedback mechanisms in regulation of norepinephrine release by nerve stimulation